Pivot Pharmaceuticals Moves to Produce CBD Products for Pets

Cannabis Investing News

Pivot Pharmaceuticals announced it decided to speed up the development of cannabidiol (CBD) products in development for the pet food market.

Pivot Pharmaceuticals (CSE:PVOT; OTCQB:PVOTF) announced it decided to speed up the development of cannabidiol (CBD) products in development for the pet food market.

As quoted in the press release:

Pivot will use its patented Ready-To-Infuse-Cannabis powder to manufacture and commercialize capsules and sachets to deliver bio-available CBD to pets. The Company will also develop and commercialize a line of pet creams using its Thrudermic Transdermal Nanotechnology. Pivot’s pet product line will be marketed under the brand “Pivot Naturals For Pets” and target indications such as joint pain, inflammation, post-surgical pain and skin disorders.
Dr. Joseph Borovksy, Pivot’s Executive Vice-President, Product Development stated “With Pivot’s line of pet products, the pain-relieving effects of CBD can be delivered orally, topically or as an additive sprinkled on pet food.

Click here to read the full press release.

Source: www.newswire.ca

Cannabis Investing